SEARCH

SEARCH BY CITATION

References

  • ADELANTADO, J.M., LOPEZ BERNAL, A. & TURNBULL, A.C. (1988). Topographical distribution of prostaglandin E receptors in human myometrium. Br. J. Obstet. Gynaecol., 95, 348353.
  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 4858.
  • BAUKNECHT, T.H., KAHE, B., RECHENBACH, U., ZAHRADNIK, H.P. & BRECHWOLDT, M. (1981). Distribution of prostaglandin E2 and prostaglandin F receptors in human myometrium. Acta Endocrinol., 98, 446450.
  • CHEGINI, N., RAO, CH.V., WAKIM, N. & SANFILIPPO, J. (1986). Prostaglandin binding to different cell types of human uterus: quantitative light microscope autoradiographic study. Prostaglandins Leukot. Med., 22, 129138.
  • CLAYTON, J.K., MARSHALL, K.M. & SENIOR, J. (1986a). A comparison of the responses to prostaglandins F, E and E analogues on human myometrium in vitro. In Abstracts for the 6th International Conference on Prostaglandins and Related Compounds p. 107. Florence, Fondazione Giovanni Lorenzini.
  • CLAYTON, J.K., MARSHALL, K.M., MASSELE, A.Y. & SENIOR, J. (1986b). Prostanoid receptors in the human myometrium in vitro. In Abstracts for the 6th International Conference on Prostaglandins and Related Compounds, Florence p. 107.Florence: Fondazione Giovanni Lorenzini.
  • COLEMAN, R.A. (1987). Methods in prostanoid receptor classification. In Prostaglandins and Related Substances, a Practical Approach. Bennedeto, C., McDonald-Gibson, R.G., Nigam, S. & Slater, T.F. pp. 267303.Oxford: IRL Press.
  • COLEMAN, R.A., HUMPHREY, P.P.A., KENNEDY, I. & LUMLEY, P. (1984). Prostanoid receptors — the development of a working classification. Trends Pharmacol. Sci., 5, 303306.
  • COLEMAN, R.A., KENNEDY, I. & SHELDRICK, R.L.G. (1985). AH6809, a prostanoid EP1-receptor blocking drug. Br. J. Pharmacol., 85, 273P.
  • COLEMAN, R.A., KENNEDY, I. & SHELDRICK, R.L.G. (1987a). Further evidence for the existence of three subtypes of PGE2-sensitive (EP-) receptors. Br. J. Pharmacol., 91, 323P.
  • COLEMAN, R.A., KENNEDY, I. & SHELDRICK, R.L.G. (1987b). New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP-) receptors. Adv. Prostaglandin Thromboxane Leukotr. Res., 17, 467470.
  • COLEMAN, R.A., KENNEDY, I., SHELDRICK, R.L.G. & TOLOWINSKA, I.Y. (1987c). Evidence for the existence of three subtypes of PGE2-sensitive (EP-) receptors. Br. J. Pharmacol., 85, 273P.
  • COLLINS, P.W., RAPPO, R. & DAJANI, E.Z. (1985). Chemistry and synthetic development of misoprostol. Dig. Dis. Sci., 30, (suppl) 114S.
  • CRANKSHAW, D.J., CRANKSHAW, J., BRANDA, L.A. & DANIEL, E.E. (1979). Receptors for the E type prostaglandins in the plasma membrane of non-pregnant human myometrium. Arch. Biochem. Biophys., 198, 7077.
  • DONG, Y.J., JONES, R.L. & WILSON, N.H. (1986). Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br. J. Pharmacol., 87, 97107.
  • DYAL, R. & CRANKSHAW, D.J. (1988). The effects of some synthetic prostanoids on the contractility of the lower uterine segment in vitro Am. J. Obstet. Gynecol., 158, 281285.
  • GARDINER, P.J. (1986). Characterisation of prostanoid relaxant/inhibitory receptors (Ψ) using a highly selective agonist, TR4979. Br. J. Pharmacol., 87, 4556.
  • GIANNOPOULOS, G., JACKSON, K., KREDENSTER, J. & TULCHINSKY, D. (1985). Prostaglandin E and F receptors in human myometrium during the menstrual cycle and in pregnancy and labour. Am. J. Obstet. Gynecol., 153, 904912.
  • GILES, H., LEFF, P., BOLOFO, M.L., KELLY, M.G. & ROBERTSON, A.D. (1989). The classification of prostanoid DP-receptors in platelets and vasculature using BWA868C, a novel, selective and potent competitive antagonist. Br. J. Pharmacol., 96, 291300.
  • HOFMANN, G.E., RAO, CH.V., BARROWS, G.H. & SANFILIPPO, J.S. (1983). Topography of human uterine prostaglandin E and F receptors and their profiles during pathological states. J. Clin. Endocrinol. Metab., 57, 360366.
  • KENNEDY, I., COLEMAN, R.A., HUMPHREY, P.P.A., LEVY, G.P. & LUMLEY, P. (1982). Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins, 24, 667689.
  • LAWRENCE, R.A. & JONES, R.L. (1992). Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br. J. Pharmacol., 105, 817824.
  • REEVES, J.J., BUNCE, K.T., SHELDRICK, R.L.G. & STABLES, R. (1988). Evidence for the PGE receptor subtype mediating inhibition of acid secretion in the rat. Br. J. Pharmacol., 95, 805P.
  • SANGER, G.J., JACKSON, A. & BENNETT, A. (1982). A prostaglandin analogue which potently relaxes human uterus but not gut muscle. Eur. J. Pharmacol., 81, 141143.
  • SANGHA, R.K. (1991). Uterine prostanoid receptors: a pharmacological analysis. PhD Thesis, University of Bradford.
  • SENIOR, J., MARSHALL, K., SANGHA, R., BAXTER, G.S. & CLAYTON, J.K. (1991). In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br. J. Pharmacol., 102, 747753.
  • SENIOR, J., SANGHA, R., BAXTER, G.S., MARSHALL, K. & CLAYTON, J.K. (1992). In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors in the non-pregnant human myometrium. Br. J. Pharmacol., 107, 215221.
  • SHELDRICK, R.L.G., COLEMAN, R.A. & LUMLEY, P. (1988). Iloprost-a potent EP1 and IP-receptor antagonist. Br. J. Pharmacol., 94, 334P.
  • SNEDECOR, G.W. & COCHRAN, W.G. (1979). Statistical Methods, 7th edition. Ames, Iowa: Iowa State University Press.
  • TOWN, M.H., CASALS-STENZEL, J. & SCHILLINGER, E. (1983). Pharmacological and cardiovascular properties of a hydantoin derivative, BW245C, with a high affinity and selectivity of PGD2 receptors. Prostaglandins, 25, 1328.
  • WAKELING, A.E. & WYNGARDEN, L.J. (1974). Prostaglandin receptors in human, monkey and hamster uterus. Endocrinology, 95, 5564.
  • WIQVIST, N., LINDBLOM, M., WIKLAND, M. & WILHELMSON, L. (1983). Prostaglandins and uterine contractility. Acta. Obstet. Gynaecol. Scand., 113 (Suppl), 2329.